New hope for transplant patients battling recurring liver disease
NCT ID NCT07335601
Summary
This study is testing whether an oral medication called resmetirom can reduce harmful fat buildup in the liver of people who have had a liver transplant. It will involve 120 participants who have developed fatty liver disease after their transplant. The main goal is to see if the drug lowers liver fat more than a placebo pill after 28 weeks of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MASH - METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dallas Methodist
Dallas, Texas, 75203, United States
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
Intermountain Medical Center
Murray, Utah, 84107, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
New York Presbyterian Hospital
New York, New York, 10065, United States
-
Northwell Health Inc, Center for Liver Disease and Transplantation
Manhasset, New York, 11030, United States
-
Northwestern University
Chicago, Illinois, 60208, United States
-
The University of Chicago Medicine
Chicago, Illinois, 60637, United States
-
University Health Network - Toronto General Hospital (TGH)
Toronto, Ontario, M5G 2C4, Canada
-
University of California Los Angeles Medical Center
Los Angeles, California, 90095, United States
-
University of California San Diego
La Jolla, California, 92037, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
University of Colorado
Aurora, Colorado, 80045, United States
-
University of Virginia Health System
Charlottesville, Virginia, 22903, United States
-
Vanderbilt University Medical Center (VUMC)
Nashville, Tennessee, 37212, United States
Conditions
Explore the condition pages connected to this study.